Zealand Pharma: plans 200 million dollar ADS issue
(CercleFinance.com) - Danish biopharma firm Zealand Pharma plans to offer and sell up to 200 million dollars of American Depositary Shares (ADS), the company said on Monday.
The offering comes as Zealand has several programs in late clinical development for specialty gastrointestinal and metabolic diseases.
Zealand shares are listed in Copenhagen, and its ADS are listed on the Nasdaq.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The offering comes as Zealand has several programs in late clinical development for specialty gastrointestinal and metabolic diseases.
Zealand shares are listed in Copenhagen, and its ADS are listed on the Nasdaq.
Copyright (c) 2019 CercleFinance.com. All rights reserved.